Back to Search Start Over

Interaction between BDNF val66met polymorphism and personality on long-term cardiac outcomes in patients with acute coronary syndrome.

Authors :
Kim JM
Stewart R
Kim SY
Kim JW
Kang HJ
Lee JY
Kim SW
Shin IS
Kim MC
Hong YJ
Ahn Y
Jeong MH
Yoon JS
Source :
PloS one [PLoS One] 2019 Dec 30; Vol. 14 (12), pp. e0226802. Date of Electronic Publication: 2019 Dec 30 (Print Publication: 2019).
Publication Year :
2019

Abstract

Background: The prognostic role of BDNF val66met polymorphism on long-term cardiac outcomes in acute coronary syndrome (ACS) has been unclear. Environmental factors may modify the association, but these have not been investigated to date. This study aimed to investigate the potential interactive effects of BDNF val66met polymorphism and personality traits, one of the main environmental prognostic factors of ACS, on major adverse cardiac events (MACEs) in patients with ACS.<br />Methods: A total of 611 patients with recent ACS were recruited at a university hospital in Korea. Baseline evaluations from 2007 to 2012 assessed BDNF val66met polymorphism and personality using the Big Five Inventory, which yielded two personality clusters (resilient and vulnerable) and five dimensions (extraversion, agreeableness, conscientiousness, neuroticism, and openness). Over a 5~12 year follow-up after the index ACS, times to MACE were investigated using Cox regression models after adjustment for a range of covariates.<br />Results: The BDNF val66met polymorphism modified the associations between vulnerable personality type and worse long-term cardiac outcomes in ACS patients with significant interaction terms, in that the associations were statistically significant in the presence met allele. Similar findings were observed for the individual personality dimensions of agreeableness and neuroticism.<br />Conclusions: Gene (BDNF val66met polymorphism) x environment (personality traits) interactions on long-term cardiac outcomes were found in ACS.<br />Competing Interests: Prof R Stewart reports research funding from Janssen and Roche, and co-supervision of a PhD with GSK. The other authors have no conflict to report related to this study. This does not alter our adherence to PLOS ONE policies on sharing data and materials.

Details

Language :
English
ISSN :
1932-6203
Volume :
14
Issue :
12
Database :
MEDLINE
Journal :
PloS one
Publication Type :
Academic Journal
Accession number :
31887219
Full Text :
https://doi.org/10.1371/journal.pone.0226802